Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
99,178,874
-
Share change
-
-30,219
-
Total reported value
-
$6,521,585,944
-
Put/Call ratio
-
152%
-
Price per share
-
$65.76
-
Number of holders
-
401
-
Value change
-
-$2,218,621
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2013
As of 31 Dec 2013 Edwards Lifesciences Corp - Common Stock (EW) had 401 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 99,178,874 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, Capital World Investors, VANGUARD GROUP INC, WELLINGTON MANAGEMENT CO LLP, State Street Corp, BlackRock Institutional Trust Company, N.A., Fairpointe Capital LLC, FMR LLC, JANA PARTNERS LLC, and BlackRock Fund Advisors.
This table shows 401 institutional shareholders of the security as of 31 Dec 2013.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.